FDA approves first mRNA-based flu vaccine
- Posted on August 6, 2026
- By CNN
- 1 Views
- 1 min read
In brief
Moderna's groundbreaking mRNA influenza vaccine has received FDA approval, marking a significant milestone in immunization technology. This novel vaccine represents the first messenger RNA-based flu prevention option available to American adults aged 50 and above. The approval demonstrates the expanding applications of mRNA platform technology beyond COVID-19 vaccines, offering potential benefits including improved efficacy and rapid development capabilities for seasonal flu protection.
Summary auto-generated by AI from the original publisher's content. Editorial standards.
FDA approves first mRNA-based flu vaccine
The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
